Goldman Sachs’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-52,553
| Closed | -$11K | – | 4434 |
|
|
2019
Q3 | $11K | Buy |
52,553
+6,118
| +13% | +$1.28K | ﹤0.01% | 4209 |
|
|
2019
Q2 | $40K | Sell |
46,435
-374
| -0.8% | -$322 | ﹤0.01% | 4101 |
|
|
2019
Q1 | $109K | Buy |
46,809
+30,109
| +180% | +$70.1K | ﹤0.01% | 4004 |
|
|
2018
Q4 | $39K | Sell |
16,700
-7,335
| -31% | -$17.1K | ﹤0.01% | 3992 |
|
|
2018
Q3 | $356K | Buy |
24,035
+10,102
| +73% | +$150K | ﹤0.01% | 3595 |
|
|
2018
Q2 | $212K | Buy |
13,933
+1,932
| +16% | +$29.4K | ﹤0.01% | 3865 |
|
|
2018
Q1 | $225K | Buy |
12,001
+1,259
| +12% | +$23.6K | ﹤0.01% | 3805 |
|
|
2017
Q4 | $195K | Buy |
+10,742
| New | +$195K | ﹤0.01% | 3834 |
|